anti E7 TCR from Creative Biolabs that has expanded to the entire new drug discovery and development pipeline, including early discovery, preclinical testing, process development, cGMP manufacturing, phase 243-III clinical trials. https://www.creative-biolabs.com/car-t/target-e7-110.htm